256
podcast episode
Ep. 34: Upside Down, with Vivek Ramaswamy
“Seeing my own family members in New York go through what they're going through has...not only tur
ned our personal life upside down, but also has turned upside down...the near-term priorities of our company to help do our part in addressing this
+ Read More
podcast episode
Ep. 35: Access, with Goldman Sachs’ David Solomon
“This is a demand shutdown in the economy that's affecting all businesses….If you're a small busin
ess, your access to capital in some cases can be limited, [so] that's why getting resources to these small businesses that employ so many is so, so
+ Read More
podcast episode
Ep. 125: Leadership, With BTG Pactual’s André Esteves
“We need to attack extreme poverty. Of course, the pandemic brought additional challenges to that.
But, we provided emergency aid for an extensive part of our population, around 60 million people.
+ Read More
podcast episode
Ep. 53: Helping Hand, with Brent McIntosh
“In America, we don't look to the government alone to develop the solutions.
podcast episode
Ep. 54: In Translation, with NCATS’ Christopher Austin
“Are we going to require the same level of evidence for a vaccine...before it is approved? Could w
e potentially begin to use it at the same time we're still studying it?
+ Read More
podcast episode
Ep. 55: Test and Isolate, with Nobel Laureate Paul Romer
“The fundamental decision that every society has to make is, can we suppress this virus forever if
necessary? Can we afford to do that?...If you know that you're going to give up, there's no point to suppress for a while.”
+ Read More
panel
Defeating a Global Enemy: Collaboration Against Cancer
The COVID-19 pandemic has proved that global cooperation and public-private partnerships can suc
cessfully strive together in times of crisis to make a tangible impact.
+ Read More
panel
Transforming Healthcare: Technology, Innovation, and Going Digital
Over the last 18 months, few sectors have been so challenged and had to adapt more quickly than
health-care delivery and epidemiology.
+ Read More
panel
Tackling Type 1 Diabetes: Where the Science is Heading
Around the world, numbers of type 1 diabetes (T1D) cases are rising. It's expected that by 2050,
5 million people in the United States alone will have been diagnosed.
+ Read More
panel
Medical Supply Chains During the Pandemic: Lessons Learned and Best Practices
The COVID-19 pandemic tested US and global supply chains by requiring the production and distrib
ution of hundreds of millions of units of key medical products at unprecedented speed.
+ Read More
panel
The Give and Take of Drug Pricing Reform
Several proposals to lower drug costs have been introduced in recent years in response to growin
g public concern about drug prices and affordability.
+ Read More
panel
Valuing Nutrition: Addressing a Hidden Epidemic
Access to nutritious foods is essential to promoting health and preventing disease.